Impact of the Everolimus-Eluting Stent on Stent Thrombosis-Reference-Cited by-同舟云学术

Impact of the Everolimus-Eluting Stent on Stent Thrombosis

Published:2011-10 Issue:15 Volume:58 Page:1569-1577
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Baber Usman,Mehran Roxana,Sharma Samin K.,Brar Somjot,Yu Jennifer,Suh Jung-Won,Kim Hyo-Soo,Park Seung-Jung,Kastrati Adnan,de Waha Antoinette,Krishnan Prakash,Moreno Pedro,Sweeny Joseph,Kim Michael C.,Suleman Javed,Pyo Robert,Wiley Jose,Kovacic Jason,Kini Annapoorna S.,Dangas George D.

Funder

Bristol-Myers Squibb/Sanofi-Aventis

The Medicines Company

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference44 articles.

1. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

2. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents;Stone;N Engl J Med,2007

3. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis;Nordmann;Eur Heart J,2006

4. Late angiographic stent thrombosis (LAST) events with drug-eluting stents;Ong;J Am Coll Cardiol,2005

5. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent;Doostzadeh;Coron Artery Dis,2010

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultrathin-strut versus thin-strut stent healing and outcomes in preclinical and clinical subjects;EuroIntervention;2024-05

2. Poor Below Knee Runoff Impacts Femoropopliteal Stent Failure and Fluoropolymer Antithrombotic Effect in Healthy Swine Model;European Journal of Vascular and Endovascular Surgery;2023-11

3. Complete Revascularization in Left Main Disease;JACC: Asia;2023-02

4. Diabetes and Cardiovascular Disease;The Diabetes Textbook;2023

5. Les dispositifs médicaux dans la prise en charge des coronaropathies en cardiologie interventionnelle;Pharmacie clinique et dispositifs médicaux;2023